Repro Med Systems Stock Investor Sentiment

KRMD Stock  USD 3.52  0.06  1.68%   
About 56% of all Repro Med's shareholders are looking to take a long position. The analysis of overall sentiment of trading Repro Med Systems stock suggests that some investors are interested at this time. The current market sentiment, together with Repro Med's historical and current headlines, can help investors time the market. In addition, many technical investors use Repro Med Systems stock news signals to limit their universe of possible portfolio assets.
  

Repro Med Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Repro Med can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a year ago at finance.yahoo.com         
The past three years for KORU Medical Systems investors has not been profitable
Yahoo News
over a year ago at insidermonkey.com         
KORU Medical Systems, Inc. Q3 2023 Earnings Call Transcript
insidermonkey News
over a year ago at seekingalpha.com         
KORU Medical Systems Non-GAAP EPS of -0.03 beats by 0.02, revenue of 7M misses by 0.93M
seekingalpha News
over a year ago at news.google.com         
2023-11-08 NDAQCYRX Press Release Cryoport Inc - Stockhouse Publishing
Google News at Macroaxis
over a year ago at gurufocus.com         
KORU Medical Systems Inc Reports Q3 2023 Financial Results and Updates Full Year Outlook
Gurufocus Stories at Macroaxis
over a year ago at finance.yahoo.com         
KORU Medical Systems Inc Reports Q3 2023 Financial Results and Updates Full Year Outlook
Yahoo News
over a year ago at businesswire.com         
KORU Medical Systems, Inc. Receives FDA 510 Clearance for FREEDOM60 Infusion System With Hizentra 50...
businesswire News
over a year ago at thelincolnianonline.com         
KORU Medical Systems Set to Announce Earnings on Wednesday
news
over a year ago at thelincolnianonline.com         
Critical Survey KORU Medical Systems versus Top Glove Co. Bhd.
news
over a year ago at news.google.com         
Prediction of human health risk and disability-adjusted life years ... - Nature.com
Google News at Macroaxis
over a year ago at news.google.com         
Understanding adolescent girls experiences with accessing and ... - BMC Public Health
Google News at Macroaxis
over a year ago at news.google.com         
The voice of Kentucky agriculture Commissioners race takes a ... - Commonwealth Journals History
Google News at Macroaxis
over a year ago at news.google.com         
Tri-City to Partner with UC San Diego Health in Delivering World ... - UC San Diego Health
Google News at Macroaxis
over a year ago at news.google.com         
Theres Been a Major Increase in Abortion Pill AccessThanks to ... - Ms. Magazine
Google News at Macroaxis
over a year ago at news.google.com         
Columnist Carrie Baker Abortion pill access rose after Dobbs ruling ... - GazetteNET
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Repro Med that are available to investors today. That information is available publicly through Repro media outlets and privately through word of mouth or via Repro internal channels. However, regardless of the origin, that massive amount of Repro data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Repro Med news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Repro Med relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Repro Med's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Repro Med alpha.

Repro Med Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Linda Tharby of 19681 shares of Repro Med at 2.09 subject to Rule 16b-3
09/20/2024
2
Acquisition by Manko Joseph M. Jr. of 5454 shares of Repro Med subject to Rule 16b-3
09/30/2024
3
Acquisition by Cascella Robert of 5454 shares of Repro Med at 2.75 subject to Rule 16b-3
10/01/2024
4
Further weakness as KORU Medical Systems drops 10 percent this week, taking five-year losses to 38
10/09/2024
5
LivaNova Tops Q3 Earnings and Revenue Estimates
10/30/2024
6
KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge Infusio...
10/31/2024
7
Disposition of 721781 shares by Manko Joseph M. Jr. of Repro Med subject to Rule 16b-3
11/08/2024
8
KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth Raises Full Year 2024 Guidance
11/13/2024
9
Koru Medical Systems stock target increased, holds buy on strong quarter
11/14/2024
10
KORU Medical Systems, Inc. Q3 2024 Earnings Call Transcript
11/15/2024
11
KRMD stock touches 52-week high at 3.41 amid robust growth - Investing.com Australia
11/21/2024

Complementary Tools for Repro Stock analysis

When running Repro Med's price analysis, check to measure Repro Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repro Med is operating at the current time. Most of Repro Med's value examination focuses on studying past and present price action to predict the probability of Repro Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repro Med's price. Additionally, you may evaluate how the addition of Repro Med to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum